5 recruiting, 1 completed, 1 enrolling by invitation, 1 terminated. 6 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 6 | Recruiting 4, Enrolling by invitation 1, Terminated 1 |
| Phase 4 | 1 | Recruiting 1 |
Follow BioLab Holdings: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects. Control Dressing + Standard of Care, CAMP + Standard of Care - Mohs Micrographic Surgery, Cutaneous Malignancy | Not applicable | Recruiting | BioLab Holdings | 160 | 2026-09-18 | 2026-10-01 |
| CAMPR-II RWE TRIAL: A Saline-hydrated Allogeneic Dual-layer Amniotic Membrane Product or a Synthetic, Resorbable Polymeric Wound Matrix to a Coarsened Exact Matched Retrospective Control Cohort of Hard to Heal DFUs and VLUs Microlyte®, IP 1: Membrane Wrap - Hydro - Wound, Foot, Diabetic Foot Ulcer (DFU) | Not applicable | Recruiting | Capsicure, LLC | 147 | 2026-06-22 | 2026-07-14 |
| BIO-SEE: Bioburden Imaging Outcome Study for Equivalence Evaluation cureVision cV - DFU, VLU | Not applicable | Enrolling by invitation | Capsicure, LLC | 100 | 2026-06-10 | 2026-06-11 |
| Efficacy of Human Placental Membrane Products and Standard of Care in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU, Membrane Wrap-Lite™ DFU - Diabetic Foot Ulcer, Foot Ulcer Chronic | Not applicable | Recruiting | BioLab Holdings | 50 | 2026-01-02 | 2026-10-01 |
| CAMP RWE Trial: Amnion Grafts for Healing Hard-to-Heal Ulcers in RW Populations IP1: BioLab Membrane Wrap Lite IP2: BioLab Tri-Membrane Wrap, IP2: BioLab Tri-Membrane Wrap - Diabetic Foot Ulcer (DFU), Venous Leg Ulcer | Not applicable | Recruiting | Capsicure, LLC | 165 | 2025-10-01 | 2025-10-22 |
| Trial Assessing the Efficacy of Human Placental Membrane Products and Standard of Care Versus Standard of Care Alone in the Management of Nonhealing Diabetic Foot Ulcers and Venous Leg Ulcers Standard of Care DFU, Tri-Membrane Wrap™ DFU, Membrane Wrap™ DFU - Diabetic Foot, DFU | Phase 4 | Recruiting | BioLab Holdings | 650 | 2025-07-15 | 2025-07-28 |
| A Real World Data Collection of Human Amniotic Membrane(s) on Diabetic Foot Ulcers, Venous Leg Ulcers, Pressure Ulcers and Post Operative Wounds Tri-Membrane Wrap™, Membrane Wrap™, Membrane Wrap-Hydro™ - Venous Leg Ulcer (VLU), Diabetic Foot Ulcer (DFU) | Completed | BioLab Holdings | 500 | 2025-04-23 | 2026-10-01 | |
| Human Amniotic Membrane On Venous Leg Ulcers In an Elderly Population Membrane Wrap™, Standard of Care - Venous Leg Ulcer | Not applicable | Terminated | BioLab Holdings | 30 | 2025-03-31 | 2026-05-27 |
Diabetic Foot (5) · Varicose Ulcer (5) · Foot Injuries (2) · Foot Ulcer (2) · Leg Ulcer (2) · Pressure Ulcer (2) · Ulcer (2) · Surgical Wound (1) · Wounds and Injuries (1)
Standard of Care (3)
United States (8)
Marshall Medley (2) · Windy Cole, DPM (2) · Thomas Serena, MD (1)